OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Driver mutations of cancer epigenomes
David M. Roy, Logan A. Walsh, Timothy A. Chan
Protein & Cell (2014) Vol. 5, Iss. 4, pp. 265-296
Open Access | Times Cited: 169
David M. Roy, Logan A. Walsh, Timothy A. Chan
Protein & Cell (2014) Vol. 5, Iss. 4, pp. 265-296
Open Access | Times Cited: 169
Showing 1-25 of 169 citing articles:
The molecular hallmarks of epigenetic control
C. David Allis, Thomas Jenuwein
Nature Reviews Genetics (2016) Vol. 17, Iss. 8, pp. 487-500
Closed Access | Times Cited: 2313
C. David Allis, Thomas Jenuwein
Nature Reviews Genetics (2016) Vol. 17, Iss. 8, pp. 487-500
Closed Access | Times Cited: 2313
Epigenetic drivers of tumourigenesis and cancer metastasis
Aniruddha Chatterjee, Euan J. Rodger, Michael R. Eccles
Seminars in Cancer Biology (2017) Vol. 51, pp. 149-159
Open Access | Times Cited: 282
Aniruddha Chatterjee, Euan J. Rodger, Michael R. Eccles
Seminars in Cancer Biology (2017) Vol. 51, pp. 149-159
Open Access | Times Cited: 282
HDAC Inhibitors in Acute Myeloid Leukemia
Edurne San José‐Eneriz, Naroa Gimenez-Camino, Xabier Agirre, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1794-1794
Open Access | Times Cited: 176
Edurne San José‐Eneriz, Naroa Gimenez-Camino, Xabier Agirre, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1794-1794
Open Access | Times Cited: 176
CancerDetector: ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data
Wenyuan Li, Qingjiao Li, Shuli Kang, et al.
Nucleic Acids Research (2018) Vol. 46, Iss. 15, pp. e89-e89
Open Access | Times Cited: 166
Wenyuan Li, Qingjiao Li, Shuli Kang, et al.
Nucleic Acids Research (2018) Vol. 46, Iss. 15, pp. e89-e89
Open Access | Times Cited: 166
Intravesical delivery of KDM6A -mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer
Na Kong, Ruonan Zhang, Gongwei Wu, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 7
Open Access | Times Cited: 123
Na Kong, Ruonan Zhang, Gongwei Wu, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 7
Open Access | Times Cited: 123
Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
Gh. Rasool Bhat, Itty Sethi, Hana Q. Sadida, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 197-228
Open Access | Times Cited: 58
Gh. Rasool Bhat, Itty Sethi, Hana Q. Sadida, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 197-228
Open Access | Times Cited: 58
Genetic alterations of histone lysine methyltransferases and their significance in breast cancer
Lanxin Liu, Sarah Kimball, Hui Liu, et al.
Oncotarget (2014) Vol. 6, Iss. 4, pp. 2466-2482
Open Access | Times Cited: 155
Lanxin Liu, Sarah Kimball, Hui Liu, et al.
Oncotarget (2014) Vol. 6, Iss. 4, pp. 2466-2482
Open Access | Times Cited: 155
DNA repair mechanisms and their clinical impact in glioblastoma
Hélène Erasimus, Matthieu Gobin, Simone P. Niclou, et al.
Mutation Research/Reviews in Mutation Research (2016) Vol. 769, pp. 19-35
Open Access | Times Cited: 155
Hélène Erasimus, Matthieu Gobin, Simone P. Niclou, et al.
Mutation Research/Reviews in Mutation Research (2016) Vol. 769, pp. 19-35
Open Access | Times Cited: 155
Targeting BET Bromodomains for Cancer Treatment
Marie Jung, Kathy A. Gelato, Amaury E. Fernández‐Montalván, et al.
Epigenomics (2015) Vol. 7, Iss. 3, pp. 487-501
Closed Access | Times Cited: 141
Marie Jung, Kathy A. Gelato, Amaury E. Fernández‐Montalván, et al.
Epigenomics (2015) Vol. 7, Iss. 3, pp. 487-501
Closed Access | Times Cited: 141
Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress
Маргарита Е. Неганова, С. Г. Клочков, Yulia Aleksandrova, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 452-471
Closed Access | Times Cited: 128
Маргарита Е. Неганова, С. Г. Клочков, Yulia Aleksandrova, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 452-471
Closed Access | Times Cited: 128
Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
Elisabeth Heßmann, Steven A. Johnsen, Jens T. Siveke, et al.
Gut (2016) Vol. 66, Iss. 1, pp. 168-179
Open Access | Times Cited: 124
Elisabeth Heßmann, Steven A. Johnsen, Jens T. Siveke, et al.
Gut (2016) Vol. 66, Iss. 1, pp. 168-179
Open Access | Times Cited: 124
Mutation of cancer driverMLL2results in transcription stress and genome instability
Theodoros Kantidakis, Marco Saponaro, Richard Mitter, et al.
Genes & Development (2016) Vol. 30, Iss. 4, pp. 408-420
Open Access | Times Cited: 115
Theodoros Kantidakis, Marco Saponaro, Richard Mitter, et al.
Genes & Development (2016) Vol. 30, Iss. 4, pp. 408-420
Open Access | Times Cited: 115
Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy
Tae‐Hyung Kim, Marc S. Tyndel, Hyeoung Joon Kim, et al.
Blood (2016) Vol. 129, Iss. 1, pp. 38-47
Open Access | Times Cited: 107
Tae‐Hyung Kim, Marc S. Tyndel, Hyeoung Joon Kim, et al.
Blood (2016) Vol. 129, Iss. 1, pp. 38-47
Open Access | Times Cited: 107
Bromodomain Histone Readers and Cancer
Abhinav K. Jain, Michelle Barton
Journal of Molecular Biology (2016) Vol. 429, Iss. 13, pp. 2003-2010
Closed Access | Times Cited: 105
Abhinav K. Jain, Michelle Barton
Journal of Molecular Biology (2016) Vol. 429, Iss. 13, pp. 2003-2010
Closed Access | Times Cited: 105
Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression
Xiaoyan Li, Julie Zhou, James P. Calvet, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 3
Open Access | Times Cited: 92
Xiaoyan Li, Julie Zhou, James P. Calvet, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 3
Open Access | Times Cited: 92
Epigenetic Enzyme Mutations: Role in Tumorigenesis and Molecular Inhibitors
Mei Han, Lina Jia, Wencai Lv, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 87
Mei Han, Lina Jia, Wencai Lv, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 87
Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA
Joanna Szczepanek, Monika Skorupa, Joanna Jarkiewicz‐Tretyn, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7235-7235
Open Access | Times Cited: 38
Joanna Szczepanek, Monika Skorupa, Joanna Jarkiewicz‐Tretyn, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7235-7235
Open Access | Times Cited: 38
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
Antonio Curcio, Roberta Rocca, Stefano Alcaro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 620-620
Open Access | Times Cited: 14
Antonio Curcio, Roberta Rocca, Stefano Alcaro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 620-620
Open Access | Times Cited: 14
Development and classes of epigenetic drugs for cancer
Dashyant Dhanak, Paul Jackson
Biochemical and Biophysical Research Communications (2014) Vol. 455, Iss. 1-2, pp. 58-69
Closed Access | Times Cited: 83
Dashyant Dhanak, Paul Jackson
Biochemical and Biophysical Research Communications (2014) Vol. 455, Iss. 1-2, pp. 58-69
Closed Access | Times Cited: 83
Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified
Mengyuan Ji, Yao‐Hui Huang, Jinyan Huang, et al.
Haematologica (2018) Vol. 103, Iss. 4, pp. 679-687
Open Access | Times Cited: 82
Mengyuan Ji, Yao‐Hui Huang, Jinyan Huang, et al.
Haematologica (2018) Vol. 103, Iss. 4, pp. 679-687
Open Access | Times Cited: 82
Composition and Function of Mutant Swi/Snf Complexes
Arnob Dutta, Mihaela E. Sardiu, Madelaine Gogol, et al.
Cell Reports (2017) Vol. 18, Iss. 9, pp. 2124-2134
Open Access | Times Cited: 76
Arnob Dutta, Mihaela E. Sardiu, Madelaine Gogol, et al.
Cell Reports (2017) Vol. 18, Iss. 9, pp. 2124-2134
Open Access | Times Cited: 76
Tumorigenic Cell Reprogramming and Cancer Plasticity: Interplay between Signaling, Microenvironment, and Epigenetics
Vittoria Poli, Luca Fagnocchi, Alessio Zippo
Stem Cells International (2018) Vol. 2018, pp. 1-16
Open Access | Times Cited: 69
Vittoria Poli, Luca Fagnocchi, Alessio Zippo
Stem Cells International (2018) Vol. 2018, pp. 1-16
Open Access | Times Cited: 69
Targeting epigenetic regulations in cancer
Bo Ning, Wenyuan Li, Wei Zhao, et al.
Acta Biochimica et Biophysica Sinica (2015) Vol. 48, Iss. 1, pp. 97-109
Open Access | Times Cited: 67
Bo Ning, Wenyuan Li, Wei Zhao, et al.
Acta Biochimica et Biophysica Sinica (2015) Vol. 48, Iss. 1, pp. 97-109
Open Access | Times Cited: 67
Genes encoding members of the JAK ‐STAT pathway or epigenetic regulators are recurrently mutated in T‐cell prolymphocytic leukaemia
Cristina López, Anke K. Bergmann, Ulrike Paul, et al.
British Journal of Haematology (2016) Vol. 173, Iss. 2, pp. 265-273
Open Access | Times Cited: 65
Cristina López, Anke K. Bergmann, Ulrike Paul, et al.
British Journal of Haematology (2016) Vol. 173, Iss. 2, pp. 265-273
Open Access | Times Cited: 65
Systemic therapies for salivary gland adenoid cystic carcinoma.
Sosuke Sahara, Alexandra E. Herzog, Jacques E. Nör
PubMed (2021) Vol. 11, Iss. 9, pp. 4092-4110
Closed Access | Times Cited: 54
Sosuke Sahara, Alexandra E. Herzog, Jacques E. Nör
PubMed (2021) Vol. 11, Iss. 9, pp. 4092-4110
Closed Access | Times Cited: 54
